importantSYS.SOURCE: TechCrunch• 2026-07-20T23:39:35Z
Colossal Biosciences Seeks $20B–$30B Valuation in New Funding Round
Colossal Biosciences is in talks to raise new capital at a $20B–$30B valuation, up from its previous $10.2B valuation. The company has diversified into multiple revenue streams, including conservation technology, AI-driven platforms, and biotech spin-offs.
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
*** END OF TRANSMISSION ***